<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364647">
  <stage>Registered</stage>
  <submitdate>22/07/2013</submitdate>
  <approvaldate>26/07/2013</approvaldate>
  <actrnumber>ACTRN12613000829718</actrnumber>
  <trial_identification>
    <studytitle>Effect of regional anaesthesia on the vessels of the upper limb in patients operated for vascular access </studytitle>
    <scientifictitle>Effect of brachial plexus block on regional hemodynamics of the upper limb in patients operated for vascular access : Supraclavicular approach versus infraclavicular approach</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>regional hemodynamics of the upper limb after brachial plexus block</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Other anaesthesiology</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Common management for both groups will include the following:

1. No pre-medication
2. Standard monitoring: ECG, non invasive blood pressure, oxymetry.
3. Peripheral venous cannulation

Supraclavicular (SB) group:
Supraclavicular block
15 ml lidocaine 2% + 15 ml bupivacaine 0.5% in a double point injection ultrasound guided supraclavicular brachial plexus block

Infraclavicular (IB) group:
Infraclavicular block
15 ml lidocaine 2% + 15 ml bupivacaine 0.5% in a triple point injection ultrasound guided infraclavicular brachial plexus block

The duration of each procedure is approximately 15 minutes</interventions>
    <comparator>Infraclavicular block</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Devices</interventioncode>
    <interventioncode>Treatment: Surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>brachial artery blood flow measured with ultrasound-doppler at mid arm
</outcome>
      <timepoint>T0: before performing the block
T15: 15 minutes after the procedure is completed
T30: 30 minutes after the procedure is completed</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>cephalic vein diameter measured with ultrasound at mid arm</outcome>
      <timepoint>T0: before performing the block
T15: 15 minutes after the procedure is completed
T30: 30 minutes after the procedure is completed</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>brachial artery pulsatility and resistivity indexes measured with ultrasound-doppler at mid arm</outcome>
      <timepoint>T0: before performing the block
T15: 15 minutes after the procedure is completed
T30: 30 minutes after the procedure is completed</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Success rate for surgical anaesthesia : seccess is defined by the absence of pain at skin incision
</outcome>
      <timepoint>40 minutes, after the procedure is completed</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients requiring hemodialysis and scheuled to elective confection of humeral-cephalic arteriovenous fistula under regional anaesthesia</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>1. Patient refusal
2. Allergy to local anesthetics
3. Existing neurological disorders, neuropathy of the operative extremity
4. Infection at site of needle puncture
5. Coagulation disorders</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Subjects for the study will be recruited from the operating list
Allocation to study groups will use sealed opaque envelops.</concealment>
    <sequence>Computer generated random number</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>8/06/2013</anticipatedstartdate>
    <actualstartdate>1/07/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate>15/08/2013</actualenddate>
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Tunisia</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Military Hospital of Tunis</primarysponsorname>
    <primarysponsoraddress>Montfleury 1089 Tunis</primarysponsoraddress>
    <primarysponsorcountry>Tunisia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Military Hospital of Tunis</fundingname>
      <fundingaddress>Montfleury 1089 Tunis</fundingaddress>
      <fundingcountry>Tunisia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>To determine whether ultrasound guided supraclavicular block provides more important increase in brachial artery blood flow and more important vasodilation of the cephalic vein than infraclavicular block.
If the primary hypothesis is confirmed, this study will provide evidence supporting the use of the supraclavicular block for the confection of humeral-cephalic arteriovenous fistula.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Military Hospital of Tunis Local Ethics Committee</ethicname>
      <ethicaddress>Military Hospital of Tunis 
Monfleury
1089
Tunis</ethicaddress>
      <ethicapprovaldate>4/06/2013</ethicapprovaldate>
      <hrec>063/013</hrec>
      <ethicsubmitdate />
      <ethiccountry>Tunisia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Radhouane Bousselmi</name>
      <address>Military Hospital of Tunis
15 Avenue de la Republique
2000
Bardo</address>
      <phone>+216 22 622 495</phone>
      <fax />
      <email>rdh.bousselmi@gmail.com</email>
      <country>Tunisia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Radhouane Bousselmi</name>
      <address>Military Hospital of Tunis
15 Avenue de la Republique
2000
Bardo</address>
      <phone>+216 22 622 495</phone>
      <fax />
      <email>rdh.bousselmi@gmail.com</email>
      <country>Tunisia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Radhouane Bousselmi</name>
      <address>Military Hospital of Tunis
15 Avenue de la Republique
2000
Bardo</address>
      <phone>+216 22 622 495</phone>
      <fax />
      <email>rdh.bousselmi@gmail.com</email>
      <country>Tunisia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>